T Cell News and Research

Latest T Cell News and Research

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

16 Dec 2010

Stem cell therapy gives sight to four year old

Izabelle Evans, only four years of age, was born blind but in a medical miracle has been given sight. After a stem cell treatment in China she can see. Her parents James Evans and Hollie McHugh are “over the moon” that their daughter can finally see them. As of now she can see only 3ft away. The treatment that cost the family £50,000.

16 Dec 2010

HIV patient cured!

German researchers working with stem cell therapy have claimed they have cured an American patient with HIV and leukemia. Experts are wary of accepting the development at its face value and caution that there is a need for further research. Dr David Scadden, a co-director of the Harvard University Stem Cell Institute added, “Cured is a strong word. But this is very encouraging… from all indications, there was no residual virus… It’s as good an outcome as one could hope for.”

16 Dec 2010

RFA highly valuable therapy for controlling cancerous nodules

16 Dec 2010

PCSBI issues 18 recommendations in emerging field of synthetic biology

The Presidential Commission for the Study of Bioethical Issues today released its first report-a wide-ranging review of the emerging field of synthetic biology-issuing 18 recommendations including a call for coordinated federal oversight of scientists working in both large institutions and smaller settings.

16 Dec 2010

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced in a comprehensive interview with analyst Francis Gaskins that the acquisition of Cyro-Cell Mexico would give CBAI a "clear path to profitability."

16 Dec 2010

Precision BioSciences receive $3 million to develop DNE technology

Precision BioSciences, today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina.

16 Dec 2010

Scientists demonstrate similarity between individual development and phylogeny in level of gene expression

Similarities in the embryonic development of various animal species are also found at molecular level. The astonishing similarity in the appearance of embryos from different animal species was observed as far back as the 19th century by scientists such as Karl von Baer, Charles Darwin and Ernst Haeckel.

16 Dec 2010

Study describes CC3/TIP30 protein regulate metabolic adaptation of tumor cells to glucose limitation

Bionovo, today announced the publication of a study entitled "CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation" in the journal Cell Cycle.

16 Dec 2010

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.

16 Dec 2010

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.

16 Dec 2010

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.

16 Dec 2010

New findings says TRIM24 protein plays active role in breast cancer formation

The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer.

16 Dec 2010

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

In a paper published in the journal PLoS One, the researchers demonstrated that culturing mouse embryonic stem cells on a soft gel rather than on a hard plate or dish keeps them in their pluripotent state, a ground state with the ability to become any type of tissue.

16 Dec 2010

PEG-Prom encased nanoparticle aids in cancer detection and treatment

In a proof of principal study in mice, scientists at Johns Hopkins and the Virginia Commonwealth University have shown that a set of genetic instructions encased in a nanoparticle can be used as an "ignition switch" to rev up gene activity that aids cancer detection and treatment.

16 Dec 2010

Novel adenovirus-based gene therapy for renal cell carcinoma

Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.

16 Dec 2010

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.

16 Dec 2010

Scientists discover potential strategy for pancreatic cancer therapy

By determining what goes missing in human cells when the gene that is most commonly mutated in pancreatic cancer gets turned on, Johns Hopkins scientists have discovered a potential strategy for therapy.

15 Dec 2010

Clinical Investigation – ground-breaking new launch from Future Science

In recognition of the methodology, progress and outcome of clinical trials, Future Science has announced the launch of the definitive title Clinical Investigation. The journal is the latest addition to the Future Science’s collection of titles addressing those areas that most impact our daily lives (available at www.future-science.com). Future Science is part of London-based Future Science Group.

15 Dec 2010

Targeting mutant BRAF can kill cancer cells, but cannot finish off melanoma

This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.

15 Dec 2010

T Cell News and Research

Latest T Cell News and Research

Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation

Stem cell therapy gives sight to four year old

HIV patient cured!

RFA highly valuable therapy for controlling cancerous nodules

PCSBI issues 18 recommendations in emerging field of synthetic biology

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

Precision BioSciences receive $3 million to develop DNE technology

Scientists demonstrate similarity between individual development and phylogeny in level of gene expression

Study describes CC3/TIP30 protein regulate metabolic adaptation of tumor cells to glucose limitation

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

New findings says TRIM24 protein plays active role in breast cancer formation

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

PEG-Prom encased nanoparticle aids in cancer detection and treatment

Novel adenovirus-based gene therapy for renal cell carcinoma

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

Scientists discover potential strategy for pancreatic cancer therapy

Clinical Investigation – ground-breaking new launch from Future Science

Targeting mutant BRAF can kill cancer cells, but cannot finish off melanoma

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in